A Study to Assess FLX-787 in Subjects With Motor Neuron Disease Experiencing Muscle Cramps.

NCT03196375 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

54

Enrollment

INDUSTRY

Sponsor class

Stopped Sponsor

Conditions

Motor Neuron Disease

Interventions

DRUG: FLX-787-ODT (orally disintegrating tablet)
DRUG: Placebo ODT

Sponsor

Flex Pharma, Inc.